Source: CURATED

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast 		0.400 Biomarker CTD_human To our knowledge, we are the first to demonstrate that the normal I.4 promoter and the breast cancer-relevant PII, I.3, and I.7 promoters of <i>CYP19</i> are active in these cells. 29701941

2018
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast 		0.400 Biomarker CTD_human Relapsed patients also developed numerous mutations targeting key breast cancer-associated genes, including ESR1 and CYP19A1. 28112739

2017
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast 		0.400 Biomarker CTD_human We can conclude that the rs10046 polymorphism on CYP19 by itself does not constitute breast cancer risk. 23342035

2013
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast 		0.400 Biomarker CTD_human These results suggest that 3-bp I/D polymorphisms of the CYP19 gene may be associated with breast cancer and that the (TTTA)n repeat genotype would be useful in selecting candidates for tamoxifen therapy, as well as predicting breast cancer risk in Korean women. 19639193

2009
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast 		0.400 Biomarker CTD_human While aromatase inhibitors are used to treat breast cancer, the treatment has been found to increase the level of aromatase in the breast tissue of some patients. 11850205

2001